Antiparasitic Nitazoxanide Tablets to Treat Intestine Infections Part 2
Drug Indications
Generic Nitazoxanide is the foremost alternative for the treatment of malady induced by Cryptosporidium parvum or Giardia lamblia (flagellate protozoan) contagion in grownups and children, capable of developing an immune response, and is a choice to be regarded in the handling of disease caused by other protozoa and/or parasitic worms. It is indicated for the intervention of infective looseness of the bowels (diarrhea) caused by Cryptosporidium parvum and Giardia lamblia in babies 1 year of age and older. Nitazoxanide is presently in Phase II clinical trials for the management of viral hepatitis C, in conjunction with peginterferon alfa-2a and Ribavirin (trade name Virazole).
Dosing Instructions
Generic Nitazoxanide is supplied in two forms of oral dosage, namely tablet in 500 mg strength and oral suspension in 100 mg per 5 ml when reconstituted.
Safety and efficacy of Generic Nitazoxanide tablets for the therapeutic intervention of diarrhea induced by Cryptosporidium parvum in patients 12 years and elder have not been showed. A solitary tablet of this medication comprises a larger quantity of Nitazoxanide than is prescribed for administration in case of infants and must therefore not be applied in pediatric patients who are equal to or less than 11 years.